Gene: CUL4A
Official Full Name: cullin 4Aprovided by HGNC
Gene Summary: CUL4A is the ubiquitin ligase component of a multimeric complex involved in the degradation of DNA damage-response proteins (Liu et al., 2009 [PubMed 19481525]).[supplied by OMIM, Oct 2009]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO03337 | CUL4A Knockout cell line (HeLa) | Human | CUL4A | 1:3~1:6 | Negative | Online Inquiry |
KO03338 | CUL4A Knockout cell line (HCT 116) | Human | CUL4A | 1:2~1:4 | Negative | Online Inquiry |
KO03339 | CUL4A Knockout cell line (HEK293) | Human | CUL4A | 1:3~1:6 | Negative | Online Inquiry |
KO03340 | CUL4A Knockout cell line (A549) | Human | CUL4A | 1:3~1:4 | Negative | Online Inquiry |
CUL4A Gene Knockout Cell Lines are a sophisticated tool designed for the exploration and functional analysis of the CUL4A gene, which encodes a core component of theCUL4-RING E3 ligase complex implicated in various cellular processes, including DNA damage repair, cell cycle regulation, and signal transduction. These knockout cell lines have been genetically engineered to enable specific disruption of the CUL4A gene, facilitating the study of its biological roles and underlying mechanisms in a controlled environment.
The key function of the CUL4A Gene Knockout Cell Lines is to serve as a precise model for understanding the consequences of CUL4A deficiency. By removing this gene, researchers can investigate its impact on protein stability, cellular proliferation, and other pathways affected by ubiquitin-mediated proteolysis. The knockout model allows for the examination of altered cellular responses to stressors such as DNA damaging agents, providing valuable insights into cancer biology, neurodegeneration, and other diseases linked to E3 ligase function.
From a scientific standpoint, these cell lines are essential for both fundamental and translational research. Their applications extend beyond basic biology; they are pivotal in drug discovery, the identification of novel therapeutic targets, and assessing the efficacy of potential treatments. Researchers can utilize these knockout lines to evaluate how perturbations in CUL4A expression influence cellular behaviors, leading to advancements in personalized medicine and the development of targeted therapies.
What sets our CUL4A Gene Knockout Cell Lines apart from alternatives is their unparalleled specificity and reproducibility. Utilizing advanced CRISPR-Cas9 technology, we ensure precise gene editing with minimal off-target effects, leading to a reliable model for experimental validation. Furthermore, these cell lines are accompanied by comprehensive user guides and assay kits that facilitate immediate application, enabling researchers to integrate them seamlessly into their workflows.
For researchers and clinicians striving to unravel the complexities of gene function and disease mechanisms, our CUL4A Gene Knockout Cell Lines represent an invaluable resource. They empower users to make significant strides in their investigations, promoting a deeper understanding of critical biological processes.
Our company boasts a robust background in the development of cutting-edge genetic tools and bioengineering solutions. We are committed to supporting the scientific community with high-quality biological products designed to accelerate research outcomes and enhance discovery.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.